Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Aufsätze"
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&filter%5B%5D=collection%3ACTG&lookfor=%22Systemic+lupus+erythematosus%22&type=Subject
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&filter%5B%5D=collection%3ACTG&lookfor=%22Systemic+lupus+erythematosus%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&filter%5B%5D=collection%3ACTG&lookfor=%22Systemic+lupus+erythematosus%22&type=Subject
PubPharm (2.016)
1
Study the efficacy and safety of VAY736 and CFZ533 in patients with systemic lupus erythematosus (SLE) : A placebo-controlled, patient and investigator blinded, randomized parallelcohort study to assess pharmacodynamics, pharmacokinetics, safety,tolerability and preliminary clinical efficacy of VAY736 and CFZ533 inpatients with systemic lupus erythematosus (SLE)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A study to evaluate the efficacy and safety of Anifrolumab compared to placebo in adult patients with Active Systemic Lupus Erythematosus : A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study to evaluate the efficacy and safety of Anifrolumab compared to placebo in adult patients with Active Systemic Lupus Erythematosus : A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
RIvaroxaban for Stroke patients with AntiPhospholipid Syndrome : Rivaroxaban versus warfarin for stroke patients with antiphospholipid syndrome, with or without SLE (RISAPS): a randomised, controlled, open-label, phase II/III, non-inferiority trial - RIvaroxaban for Stroke patients with AntiPhospholipid Syndrome
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A study to evaluate the efficacy and safety of Anifrolumab compared to placebo in adult patients with Active Systemic Lupus Erythematosus : A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Phase IIb study of IFN-K in Systemic Lupus Erythematosus : A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNa-Kinoid in Adult Subjects with Systemic Lupus Erythematosus - Phase IIb study of IFN-K in Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Phase IIb study of IFN-K in Systemic Lupus Erythematosus : A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNa-Kinoid in Adult Subjects with Systemic Lupus Erythematosus - Phase IIb study of IFN-K in Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Study the efficacy and safety of VAY736 and CFZ533 in patients with systemic lupus erythematosus (SLE) : A placebo-controlled, patient and investigator blinded, randomized parallelcohort study to assess pharmacodynamics, pharmacokinetics, safety,tolerability and preliminary clinical efficacy of VAY736 and CFZ533 inpatients with systemic lupus erythematosus (SLE)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A study to evaluate the efficacy and safety of Anifrolumab compared to placebo in adult patients with Active Systemic Lupus Erythematosus : A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A study to evaluate the efficacy and safety of Anifrolumab compared to placebo in adult patients with Active Systemic Lupus Erythematosus : A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[202]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Medienart: E-Artikel
Medienart
2.016
Aufsätze
E-Artikel
2.016
E-Ressourcen
Zeitschriftentitel
1.642
WHO International Clinical Trials Registry Plat...
374
ClinicalTrials.gov
Thema
2.016
610
1.687
Study Type: Interventional
845
Recruitment Status: Not yet recruiting
506
Phase: Phase 2
379
Recruitment Status: Completed
374
Lupus Erythematosus, Systemic
342
Phase: Phase 3
299
Study Type: Observational
297
Recruitment Status: Recruiting
293
Medical Condition: Systemic Lupus Erythematosus
266
Recruitment Status: Authorised-recruitment may ...
89
Phase: Phase 1
88
Medical Condition: Systemic lupus erythematosus
58
Medical Condition: systemic lupus erythematosus
58
Phase: Phase 4
45
Recruitment Status: Terminated
42
Recruitment Status: Complete: follow-up complete
39
Recruitment Status: Unknown status
38
Medical Condition: Systemic Lupus Erythematosus...
38
Medical Condition: Systemic lupus erythematosus...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.146
2020-
851
2010-2019
19
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.984
Englisch
20
Unbestimmt
10
Spanisch
2
Italienisch
Haven't found what you're looking for?
Wird geladen...